Using an animal model mimicking the human disease, the team demonstrated that eliminating senescent cells with a senolytic drug relived multiple symptoms and improved systemic health.

Published in Cardiovascular Research, these findings represent a milestone in the merging of anti-ageing and cardiovascular medicine.